Scabies (sarcoptic mange)

Scabies, commonly known as sarcoptic mange, represents one of the most significant ectoparasitic diseases affecting farm animals worldwide. This highly contagious skin condition is caused by microscopic burrowing mites of the genus Sarcoptes, specifically Sarcoptes scabiei, which tunnel into the superficial layers of the skin to feed, reproduce, and complete their life cycle. The disease causes intense irritation, severe pruritus, and progressive skin damage that can dramatically impact animal welfare, productivity, and economic returns for livestock producers. Understanding the nature of this parasitic infestation is essential for effective herd management and disease control strategies.

Sarcoptic mange affects a wide range of livestock species, with pigs being particularly susceptible to severe infestations. Cattle, sheep, goats, llamas, and alpacas are also commonly affected, though the specific Sarcoptes variety may differ slightly between host species. The disease has a worldwide distribution and remains endemic in many livestock production regions despite available treatments. Prevalence varies significantly based on management practices, housing conditions, climate, and the effectiveness of biosecurity measures implemented on individual farms. In some regions, particularly where intensive farming practices predominate, subclinical infections can persist in herds for extended periods without obvious clinical signs.

The economic and welfare impacts of sarcoptic mange are substantial and multifaceted. Affected animals experience significant discomfort due to the intense itching caused by mite activity and the host's allergic response to mite proteins, feces, and eggs deposited in the skin. This constant irritation leads to reduced feed intake, decreased weight gain, lower milk production in dairy animals, and diminished reproductive performance. Hide and fleece damage from scratching and rubbing behavior further compounds economic losses. Additionally, the zoonotic potential of sarcoptic mange poses occupational health risks for farmers, veterinarians, and others who handle infected animals, as temporary infestations can occur in humans through direct contact.

Early detection and prompt treatment of sarcoptic mange are critical for successful disease management and prevention of widespread herd infections. The condition is highly treatable when identified early, with several effective antiparasitic medications available for livestock use. However, delayed diagnosis or inadequate treatment protocols can allow mite populations to expand rapidly, making eradication increasingly difficult and costly. Producers should work closely with their veterinarians to establish monitoring protocols, implement appropriate treatment regimens, and develop comprehensive prevention strategies that protect herd health and maintain productivity while addressing the welfare needs of affected animals.

The primary cause of scabies in farm animals is infestation with microscopic mites belonging to the genus Sarcoptes. Sarcoptes scabiei is the species responsible, with various host-adapted varieties affecting different livestock species. Sarcoptes scabiei var. suis primarily affects pigs, while Sarcoptes scabiei var. bovis targets cattle, and Sarcoptes scabiei var. ovis infests sheep. These tiny arachnids measure only 0.2 to 0.4 millimeters in length, making them invisible to the naked eye. Female mites burrow into the stratum corneum of the skin, creating tunnels where they deposit eggs and fecal material. The entire life cycle, from egg to adult, takes approximately two to three weeks, allowing populations to expand rapidly under favorable conditions.

While sarcoptic mange is not considered a hereditary condition, certain genetic factors may influence individual animal susceptibility to severe infestations. Animals with compromised immune systems, whether due to genetic predisposition, concurrent disease, nutritional deficiencies, or stress, often develop more severe clinical signs and may serve as reservoir hosts that maintain infection within herds. Some breeds appear more susceptible than others, though this may relate more to management practices and environmental exposures than true genetic susceptibility. Young animals and those with immature or weakened immune responses are particularly vulnerable to rapid disease progression.

Environmental and management factors play crucial roles in the transmission and persistence of sarcoptic mange within livestock populations. The mites spread primarily through direct contact between infested and susceptible animals, making crowded housing conditions, communal feeding areas, and shared equipment significant risk factors. While Sarcoptes mites have limited survival capacity off the host, typically surviving only two to three days in the environment under optimal conditions, contaminated bedding, grooming equipment, and handling facilities can serve as temporary fomites for transmission. Cool, moist conditions favor mite survival, making autumn and winter months peak periods for disease transmission in temperate climates.

Several risk factors increase the likelihood of sarcoptic mange development and severity in farm animal populations. Age represents a significant factor, with young stock and geriatric animals often experiencing more severe disease presentations. Production stage influences susceptibility, as animals under physiological stress from lactation, pregnancy, or rapid growth may have reduced capacity to mount effective immune responses. Housing density, ventilation quality, nutritional status, and the presence of concurrent diseases all impact disease dynamics. Introduction of new animals without adequate quarantine and screening procedures represents one of the most common routes for mange introduction into previously unaffected herds.

The pathophysiology of sarcoptic mange involves both direct tissue damage from mite burrowing activity and an intense host inflammatory and allergic response. As female mites tunnel through the epidermis, they cause mechanical destruction of skin cells and release enzymes that facilitate their movement and feeding. The host immune system responds to mite antigens, feces, and eggs with a type IV hypersensitivity reaction that produces the characteristic intense pruritus. This allergic component explains why clinical signs often worsen with repeated exposure and why previously sensitized animals may develop severe reactions even with relatively low mite burdens. The resulting inflammation leads to hyperkeratosis, crusting, and thickening of the skin that characterizes chronic mange infestations.

Early warning signs of sarcoptic mange often begin subtly and may be overlooked during routine herd observations. Initial symptoms typically include localized areas of mild skin irritation, slight hair loss, and increased scratching or rubbing behavior in affected animals. Producers may notice animals spending excessive time scratching against posts, fences, or other objects in their environment. Small areas of reddened, irritated skin may appear, particularly in regions where mite activity is concentrated. In pigs, early lesions commonly appear around the ears, eyes, and snout, while cattle often show initial signs on the head, neck, and tail base. Detecting these early manifestations requires careful observation and regular handling of animals to assess skin condition.

Common symptoms vary somewhat between species, though the hallmark signs of intense itching and progressive skin damage are consistent across all affected livestock. In swine, sarcoptic mange produces characteristic thick, crusty lesions that begin on the head and ears before spreading across the body. Affected pigs develop a rough, wrinkled skin appearance with grayish-brown crusting and marked thickening of the skin. Cattle with sarcoptic mange display hair loss, crusting, and thickening of the skin, typically beginning on the head, neck, and brisket before potentially spreading to involve larger body areas. Sheep and goats may develop lesions on the face, ears, and legs, with wool loss and skin thickening in affected areas. Camelids such as llamas and alpacas often show lesions on the legs, belly, and axillary regions.

Behavioral changes associated with sarcoptic mange significantly impact animal welfare and productivity. Affected animals become restless and irritable due to the constant pruritus that characterizes this condition. They may exhibit reduced feed intake as the discomfort interferes with normal feeding behavior, leading to weight loss and decreased production efficiency. Social dynamics within groups may shift as heavily affected individuals isolate themselves or are avoided by herdmates. Sleep disturbance is common, as animals frequently interrupt rest periods to scratch affected areas. In severe cases, animals may become aggressive when handled due to pain and irritation associated with skin manipulation.

Physical examination of animals with sarcoptic mange reveals characteristic skin changes that progress in severity without treatment. The skin becomes increasingly thickened and corrugated, with heavy crusting and scale formation in advanced cases. Alopecia spreads from initial focal areas to involve larger body regions as mite populations expand. Secondary bacterial infections frequently complicate the clinical picture, leading to pustule formation, increased exudation, and more severe skin damage. In cattle, the skin may take on a characteristic elephant-like appearance with deep folds and fissures. Weight loss becomes apparent as the disease progresses, and general body condition deteriorates despite adequate nutrition being available.

Symptom progression follows a relatively predictable pattern if left untreated. Initial focal lesions expand and coalesce over weeks to months, eventually affecting large portions of the body surface. The skin becomes increasingly damaged, with crusts sometimes reaching several centimeters in thickness in severe cases. Animals develop a characteristic unpleasant odor associated with the accumulating crusts and secondary infections. Chronic infestations can lead to permanent skin damage, scarring, and persistent changes in hair or wool growth even after successful treatment. The cumulative effects of chronic disease significantly impact animal welfare and productivity.

Emergency symptoms requiring immediate veterinary intervention include severe generalized skin involvement, extensive secondary bacterial infection, signs of sepsis, severe weight loss, or collapse. Animals with extremely heavy mite burdens may develop life-threatening complications including dehydration, electrolyte imbalances, and overwhelming secondary infections. Young animals are particularly vulnerable to severe disease outcomes. Any animal showing signs of systemic illness in conjunction with skin lesions suggestive of mange requires prompt veterinary assessment and aggressive supportive care. Producers should also seek immediate consultation when multiple animals develop clinical signs simultaneously, as this suggests active transmission and necessitates rapid implementation of herd-wide control measures.

Clinical examination forms the foundation of sarcoptic mange diagnosis in farm animals. Veterinarians assess the characteristic distribution of lesions, the nature of skin changes, and the presence of intense pruritus that typifies this condition. The ear-scratch reflex, where rubbing or scratching the ear margin produces a scratching response from the hind leg, is particularly useful in pigs and provides strong presumptive evidence of sarcoptic mange. Physical examination includes assessment of lesion distribution, skin thickness, presence of crusting and scale formation, and evaluation of secondary complications. The pattern of lesion progression and response to previous treatments provide additional diagnostic information. A thorough history regarding herd health, recent introductions, and previous mange issues helps contextualize clinical findings.

Definitive diagnosis of sarcoptic mange requires demonstration of mites, eggs, or fecal pellets through microscopic examination of skin scrapings. Multiple deep skin scrapings should be collected from the margins of active lesions, where mite populations are typically highest. The scraping technique involves using a scalpel blade to scrape the skin until capillary bleeding occurs, ensuring collection of material from the deeper epidermal layers where mites reside. Collected material is placed in mineral oil or potassium hydroxide solution and examined under low magnification microscopy. Due to the burrowing habits of Sarcoptes mites and their relatively low numbers compared to other mange mites, multiple scrapings from several sites may be necessary, and false-negative results are not uncommon. In pigs, scrapings from the inner ear pinnae often yield the highest mite recovery rates.

Differential diagnosis for sarcoptic mange includes other causes of pruritic skin disease in livestock. Other mange types, including chorioptic mange and psoroptic mange, produce similar clinical signs but have different treatment implications and epidemiological patterns. Lice infestations can cause intense itching and should be ruled out through careful examination. Dermatophytosis (ringworm), photosensitization, and various allergic conditions may present with similar skin changes. In pigs, conditions such as exudative epidermitis (greasy pig disease) and pityriasis rosea may be confused with mange. Careful clinical examination combined with appropriate diagnostic testing allows differentiation between these conditions.

Herd-level diagnostics provide valuable information for managing sarcoptic mange in livestock populations. Serological testing using ELISA (enzyme-linked immunosorbent assay) can detect antibodies against Sarcoptes mites and is particularly useful for identifying subclinically infected animals that may serve as reservoir hosts. This approach is especially valuable in swine herds where subclinical infections are common. Herd screening protocols help determine the extent of infection and guide treatment decisions. Examination of multiple animals from different management groups assists in understanding disease distribution within the herd. Postmortem examination of skin from culled animals can provide diagnostic confirmation and help assess the effectiveness of control programs. Veterinary consultation is essential for developing appropriate diagnostic strategies based on herd history, clinical presentation, and management goals.

Emergency and immediate treatment of sarcoptic mange focuses on providing relief from the intense pruritus while initiating antiparasitic therapy. Animals with severe infestations may require supportive care including fluid therapy if dehydration is present, nutritional support, and management of secondary bacterial infections. Isolation of severely affected individuals prevents continued transmission to herdmates while treatment takes effect. Initial cleansing of heavily crusted areas may improve antiparasitic penetration and provide some immediate comfort. Anti-inflammatory medications may be considered in severe cases to reduce the allergic component of the disease, though these should be used judiciously and under veterinary guidance. Pain management is an important welfare consideration in severely affected animals.

Medical management of sarcoptic mange in farm animals relies primarily on systemic antiparasitic medications, with product selection based on species, production status, and regulatory requirements. Macrocyclic lactones, including ivermectin and doramectin, are highly effective against Sarcoptes mites when administered according to labeled protocols. These products are typically given as injectable formulations, with repeat treatments necessary to eliminate mites that emerge from eggs after initial treatment. Treatment intervals of ten to fourteen days are commonly recommended to break the mite life cycle. Pour-on formulations are available for some species and may be preferred in certain management situations. Critically, producers must observe all withdrawal periods for meat and milk to ensure food safety compliance. Withdrawal times vary between products and formulations, and veterinary guidance is essential for selecting appropriate treatments in food-producing animals.

Topical treatments may be used as adjuncts to systemic therapy or as alternatives when systemic treatment is contraindicated. Lime sulfur solutions, amitraz (where approved), and various acaricidal dips have historical use in mange treatment, though their effectiveness may be limited compared to systemic macrocyclic lactones. Topical treatments require thorough application to all body surfaces and often need repeated applications. Removal of heavy crusts before topical application improves drug penetration and treatment efficacy. Environmental treatment of housing, equipment, and bedding reduces reinfection risk during the treatment period. While topical approaches may be labor-intensive, they can be valuable components of comprehensive treatment programs.

Supportive care measures enhance treatment success and improve animal welfare during recovery. Nutritional support through high-quality feed helps animals rebuild body condition lost during active disease. Management of secondary bacterial infections may require appropriate antimicrobial therapy, again with careful attention to withdrawal periods in food animals. Wound care for severely damaged skin promotes healing and reduces scarring. Provision of clean, dry bedding and protection from environmental extremes supports the healing process. Stress reduction through appropriate handling and minimal disturbance allows immune function to support recovery.

Herd treatment protocols are essential for successful mange elimination and prevention of recurrence. Treating all animals in affected groups simultaneously prevents cycling of infection between treated and untreated individuals. Strategic treatment timing, such as treating all animals at turnout or housing, can simplify logistics and improve compliance. Multiple treatment rounds are typically necessary to eliminate mite populations completely, as eggs within the skin are not killed by most antiparasitic drugs. Whole-herd treatment may be more cost-effective than selective treatment in heavily affected populations. Coordination of treatment with cleaning and disinfection of the environment maximizes program effectiveness.

Treatment decisions in farm animal practice often involve economic considerations that influence approach selection. The cost of treatment must be weighed against the value of affected animals and the potential losses from continued disease. In severe cases, particularly in low-value animals or those with extensive secondary complications, culling may be more economically rational than prolonged treatment. However, animal welfare considerations should always factor into these decisions. Individual animal treatment may be appropriate for valuable breeding stock, while blanket herd treatments may be more practical for commercial production groups. Veterinary guidance helps producers balance economic realities with animal welfare responsibilities and disease control objectives.

Recovery timeline for sarcoptic mange varies based on disease severity, treatment protocol, and individual animal factors. Animals with mild, early-stage infections may show significant improvement within two to three weeks of initiating appropriate treatment. Moderate infestations typically require four to eight weeks for substantial clinical improvement, while severe chronic cases may need three months or longer for complete resolution of skin lesions. The intense pruritus usually diminishes within days of effective treatment as mite populations decline. Hair regrowth begins as skin damage heals, though complete coat restoration may take several months. Producers should maintain realistic expectations and continue monitoring throughout the recovery period.

Post-treatment care and monitoring are essential components of successful mange management. Animals should be re-examined two to three weeks after completing treatment to assess response and determine whether additional treatment rounds are necessary. Skin scrapings may be repeated to confirm mite elimination, though the timing of follow-up testing should account for the life cycle of any remaining mites. Continued observation for recurrence of scratching behavior or lesion development helps identify treatment failures early. Nutritional support should continue throughout recovery to support weight regain and tissue repair. Protection from environmental stressors and careful handling minimize additional demands on recovering animals.

Prognosis for sarcoptic mange depends on several factors including disease duration before treatment, severity of skin involvement, presence of complications, and effectiveness of herd-level control measures. Animals treated early in the disease course generally have excellent prognoses for complete recovery with minimal lasting effects. Chronic cases with extensive skin damage may retain permanent scarring, altered hair growth patterns, or persistent skin thickening even after successful mite elimination. Animals with severe secondary infections or systemic complications have more guarded prognoses. Young animals and those with compromised immune function may require more intensive management during recovery.

Return to production considerations include both animal welfare and economic factors. Animals recovering from mange should demonstrate resolution of pruritus, progressive healing of skin lesions, and return to normal behavior patterns before resuming full production activities. Weight regain and body condition improvement indicate successful recovery. Breeding animals should be fully recovered before returning to reproductive service to prevent transmission to offspring or breeding partners. Dairy animals returning to production must have completed all withdrawal periods for any medications used during treatment. Market animals should have adequate time for skin healing before sale to avoid carcass trim losses or rejection. Documentation of treatment and withdrawal periods is essential for maintaining food safety compliance and traceability requirements.

Vaccination protocols for sarcoptic mange are not currently available as a prevention strategy. Unlike some infectious diseases, there are no commercially available vaccines that protect against Sarcoptes mite infestation. Prevention therefore relies entirely on management practices, biosecurity measures, and strategic use of antiparasitic treatments. Research continues into potential immunological approaches to mange control, but practical vaccination options remain unavailable for livestock producers. This reality underscores the importance of other preventive measures in comprehensive herd health programs.

Biosecurity measures form the cornerstone of sarcoptic mange prevention in farm animal populations. Quarantine of all incoming animals for a minimum of three to four weeks before introduction to the main herd allows observation for clinical signs and, ideally, prophylactic treatment regardless of apparent health status. Source verification and health history review help assess risk associated with new acquisitions. Avoiding purchase of animals from unknown sources or facilities with known mange problems reduces introduction risk. Isolation of animals returning from shows, sales, or breeding leases prevents potential transmission to the home herd. Visitor policies that limit unnecessary animal contact and require clean clothing and footwear protect against fomite transmission.

Nutritional prevention focuses on maintaining optimal immune function through balanced, species-appropriate diets. Animals receiving adequate nutrition are better able to mount immune responses that limit mite population expansion and disease severity. Trace mineral supplementation, particularly zinc and copper, supports skin health and immune function. Vitamin A and E adequacy contributes to epithelial integrity and antioxidant protection. Avoiding nutritional deficiencies that compromise immune competence reduces disease susceptibility. Body condition monitoring helps identify animals that may be nutritionally stressed and at increased risk.

Management practices that reduce disease transmission risk include maintaining appropriate stocking densities to minimize direct contact between animals. Regular cleaning and disinfection of housing facilities, handling equipment, and shared resources removes environmental contamination. Prompt identification and treatment or removal of affected individuals prevents amplification of mite populations within the herd. Strategic antiparasitic treatment programs, such as treating all animals at housing in autumn, can prevent winter disease outbreaks in endemic areas. Breeding and replacement stock selection from mange-free sources maintains herd health status.

Quarantine and testing protocols provide systematic approaches to preventing mange introduction and spread. Incoming animals should be physically separated from resident stock during the quarantine period, ideally in facilities with separate air space, equipment, and caretakers. Veterinary examination during quarantine allows detection of suspicious lesions before exposure to the main herd. Prophylactic treatment of all incoming animals with effective antiparasitic products provides additional protection even when clinical signs are absent. Regular monitoring of sentinel animals or strategic sampling programs can detect subclinical herd infections before widespread clinical disease develops. Record keeping that documents animal movements, treatments, and health observations supports effective disease tracing and prevention efforts.

Daily management and monitoring for sarcoptic mange prevention requires systematic observation of all animals for early signs of skin disease. Handlers should note any animals exhibiting increased scratching or rubbing behavior during routine activities. Regular hands-on examination of animals during handling for other purposes provides opportunities to detect skin changes before they become advanced. Particular attention should be paid to common predilection sites for early lesion development. Recording observations in herd health logs creates documentation that helps identify patterns and track individual animal histories. Training farm personnel to recognize early mange signs improves detection rates and allows prompt intervention.

Housing and environmental management significantly impact sarcoptic mange transmission dynamics. Adequate space allowances reduce direct contact between animals and lower transmission rates. Proper ventilation reduces humidity that favors mite survival and helps maintain skin and coat health. Regular cleaning of housing removes accumulated organic material that may harbor mites or facilitate their survival. Bedding management, including frequent replacement of contaminated material, reduces environmental mite loads. Shared equipment such as brushes, blankets, and handling tools should be cleaned and disinfected between use on different animal groups. Separate housing or handling facilities for quarantine animals prevents cross-contamination.

Herd health programs that incorporate mange monitoring and control provide structured approaches to disease management. Regular veterinary visits should include skin examination as part of comprehensive health assessments. Risk-based monitoring strategies may target high-risk groups such as young stock or newly introduced animals. Integration of mange control with other parasite management programs improves efficiency and compliance. Development of written protocols for mange prevention, detection, and response ensures consistent implementation regardless of personnel changes. Review and adjustment of programs based on outcomes and emerging challenges maintains their effectiveness.

Record keeping and monitoring systems support effective mange management through documentation of animal health observations, treatments administered, and outcomes achieved. Individual animal identification linked to health records allows tracking of disease history and treatment responses. Herd-level data analysis can identify risk factors, seasonal patterns, or problem areas that inform management adjustments. Treatment records must document products used, dosages, dates, and withdrawal periods for food safety compliance. Monitoring of production parameters such as growth rates and reproductive performance may reveal subclinical disease impacts that warrant investigation. Regular review of records during veterinary consultations improves collaborative decision-making.

Economic considerations in mange management balance prevention costs against potential disease losses. Investment in biosecurity infrastructure and protocols yields returns through reduced disease incidence and associated production losses. Treatment costs, including medications, labor, and withdrawal period impacts, should be factored into disease response planning. Economic analysis may support culling decisions for severely affected low-value animals versus prolonged treatment. Insurance implications of mange outbreaks may influence management approaches. Long-term economic sustainability requires balancing immediate costs against the cumulative benefits of maintaining mange-free or mange-controlled herd status.

High-risk breeds and species for sarcoptic mange include pigs, which are particularly susceptible to severe clinical disease and serve as important reservoir hosts for the parasite. Among swine, all breeds are susceptible, though intensively raised commercial pigs in close confinement may experience rapid disease spread. Cattle of all breeds can develop sarcoptic mange, with dairy breeds potentially experiencing greater production impacts due to their higher metabolic demands. Sheep breeds with fine, dense wool may develop more severe skin damage due to the warm, moist environment created by heavy fleece. Goats appear somewhat less commonly affected but can develop significant clinical disease. Camelids including llamas and alpacas are susceptible and may develop severe infestations, particularly in fiber-producing animals where skin health is economically critical.

Production type considerations influence both disease risk and impact in affected herds. Dairy cattle with sarcoptic mange may experience significant milk production losses due to the stress and discomfort associated with severe pruritus. Beef cattle in feedlot settings face rapid disease transmission risk due to close confinement and contact between animals from multiple sources. Breeding stock of all species may experience reproductive impacts from severe infestations, and mange-affected animals should not be used for breeding until fully recovered. Meat-producing animals face carcass quality issues if skin damage is present at slaughter. Wool and fiber-producing animals experience direct product losses from fleece damage and may have hide value reductions at processing.

Genetic selection and testing for mange resistance are limited by the nature of disease susceptibility. Unlike some genetic conditions, there are no specific genetic markers for mange resistance that allow selective breeding. However, selection for overall immune competence and general disease resistance may provide indirect benefits. Animals that recover poorly from mange or experience repeated severe infestations despite adequate treatment may warrant removal from breeding programs. Maintaining closed herds or sourcing replacements from mange-free populations represents a more practical approach than attempting genetic selection. Progeny from animals with strong immune function and good disease resistance may have improved capacity to limit mite populations and clinical disease, though this relationship requires further research for confirmation.

Commonly co-occurring conditions with sarcoptic mange include other ectoparasite infestations that may be present simultaneously on affected animals. Lice infestations frequently accompany mange, particularly in animals with compromised skin health or immune function. Secondary bacterial skin infections (pyoderma) commonly develop in mange-damaged skin, complicating the clinical picture and requiring additional treatment. Nutritional deficiencies that predispose to severe mange may also cause other health problems. Immune compromise from concurrent diseases may allow mange to flourish and complicate recovery. Stress-related conditions may develop or worsen in animals experiencing chronic discomfort from severe infestations.

Conditions with similar symptoms that may be confused with sarcoptic mange include other mange types such as chorioptic mange (leg mange in cattle) and psoroptic mange (sheep scab). These conditions have different treatment requirements and regulatory implications. Lice infestations cause pruritus and hair loss but are typically diagnosed through visualization of the parasites. Dermatophytosis (ringworm) produces circular areas of hair loss but usually lacks the intense pruritus characteristic of mange. Photosensitization causes skin damage in light-colored or unpigmented areas. Allergic skin conditions including insect hypersensitivity may produce pruritus and skin changes. Zinc deficiency in pigs causes skin lesions that may resemble mange. Proper diagnostic workup is essential for accurate diagnosis and appropriate treatment selection.

Complications and sequelae of sarcoptic mange include permanent skin scarring and altered hair growth in areas of severe chronic damage. Secondary bacterial infections may progress to deeper tissues or cause systemic illness in severe cases. Chronic weight loss and poor body condition can have lasting impacts on growth and production potential. Hide damage from extensive scratching reduces leather quality at processing. Repeated or chronic infestations may sensitize animals to mite antigens, leading to more severe reactions with subsequent exposures. Welfare impacts from chronic discomfort can affect behavior and social interactions even after mite elimination. Economic losses from production impacts, treatment costs, and market value reductions represent significant consequences of this parasitic disease.